emerg
virus
ebola
viru
ebov
lassa
viru
lasv
avian
influenza
viru
aiv
global
health
concern
sinc
limit
option
either
vaccin
specif
therapi
approv
human
virus
urgent
need
develop
prophylact
therapeut
treatment
previous
report
highthroughput
screen
ht
protocol
identifi
entri
inhibitor
three
highli
pathogen
virus
ebov
lasv
aiv
use
human
immunodefici
virusbas
pseudotyp
platform
allow
us
perform
screen
facil
report
adopt
screen
protocol
evalu
tradit
chines
medicin
tcm
effort
discov
entri
inhibitor
virus
show
extract
follow
chines
medicin
herb
exhibit
potent
antiebola
viral
activ
gardenia
jasminoid
elli
citru
aurantium
l
viola
yedoensi
makino
prunella
vulgari
l
coix
lacrymajobi
l
var
mayuen
roman
stapf
pinellia
ternata
thunb
breit
moru
alba
l
studi
repres
proofofprincipl
investig
support
suitabl
assay
rapid
screen
tcm
identifi
put
entri
inhibitor
virus
emerg
reemerg
virus
pose
sever
global
health
concern
four
influenza
pandem
last
year
exampl
virus
impact
human
avian
influenza
virus
pose
signific
threat
anim
human
health
sourc
genet
divers
permit
emerg
pandem
influenza
mean
genet
reassort
prevail
human
influenza
virus
highli
pathogen
avian
influenza
viru
caus
diseas
outbreak
poultri
china
seven
east
asian
countri
guan
et
al
recent
ebola
viru
ebov
outbreak
west
africa
underscor
unprepared
human
deal
deadli
viru
ebov
marburg
viru
marv
belong
filoviru
famili
filovirada
caus
rapidli
lethal
hemorrhag
fever
human
sinc
outbreak
ebov
marv
occur
repeatedli
unpredictedli
new
strain
show
high
mortal
rate
towner
et
al
lassa
viru
member
arenavirida
famili
repres
two
import
etiolog
agent
viral
hemorrhag
fever
nichol
et
al
sinc
clinic
approv
antivir
therapeut
vaccin
virus
limit
urgent
need
discov
develop
antivir
either
target
one
particular
viru
broadli
target
multipl
virus
tradit
chines
medicin
play
import
role
human
healthcar
china
asia
thousand
year
also
valuabl
sourc
new
drug
discoveri
modern
medicin
knowledg
therapeut
benefit
chines
medicin
increas
research
effort
previous
serendipit
treatment
discov
new
medicin
greatli
intensifi
natur
product
includ
chines
medicin
continu
rich
sourc
new
drug
discov
newman
cragg
sinc
larg
structur
divers
complex
remain
unmatch
drug
format
rosen
et
al
artemisinin
also
known
qing
hao
su
chines
origin
isol
plant
artemisia
annua
l
semisynthet
deriv
group
drug
possess
rapid
action
current
drug
plasmodium
falciparum
malaria
white
illustri
exampl
new
antimicrobi
drug
discov
chines
medicin
herb
tetrandrin
isol
identifi
activ
ingredi
chines
medicin
herb
stephania
tetrandra
radix
report
inhibit
ebov
infect
vitro
vivo
sakurai
et
al
also
antiinfluenza
drug
discoveri
effort
natur
product
seen
rapid
increas
recent
year
wang
et
al
studi
adopt
previous
develop
highthroughput
screen
ht
assay
identifi
entri
inhibitor
three
highli
pathogen
virus
chines
medicin
extract
demonstr
protocol
allow
one
identifi
specif
share
entri
inhibitor
differ
virus
greatli
reduc
number
fals
posit
allevi
major
problem
ht
ht
format
amen
quickli
screen
antivir
inhibitor
natur
product
includ
chines
medicin
herb
human
embryon
kidney
cell
human
lung
epitheli
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
cellgro
manassa
va
supplement
fetal
bovin
serum
sigma
loui
mo
mgml
streptomycin
u
penicillin
gibco
grand
island
ny
pseudovirion
ht
creat
follow
plasmid
hemagglutinin
ha
isol
highli
pathogen
avian
influenza
viru
agooseqinghai
strain
guo
et
al
ebola
viru
zair
envelop
glycoprotein
gp
manicassami
rong
lasv
envelop
gp
radoshitzki
et
al
provir
vector
et
al
obtain
nation
institut
health
nih
aid
research
refer
reagent
program
pseudovirion
three
virus
amplifi
cell
tradit
chines
herb
purchas
zhonglu
hospit
shandong
univers
tradit
chines
medicin
jinan
china
extract
medicin
plant
obtain
accord
chines
pharmacopoeia
pharmacopoeia
peopl
republ
china
four
hundr
twentyseven
extract
differ
polar
obtain
differ
herb
plant
dri
vacuum
redissolv
dmso
pb
differ
polar
solvent
one
millilit
solut
equal
g
dri
herb
materi
two
hundr
ten
uniqu
extract
array
plate
mgml
stock
concentr
solvent
leav
column
dmso
pb
posit
control
assay
azidothymidin
azt
sigma
st
loui
mo
solubil
mm
dmso
three
type
pseudovirion
avian
influenza
viru
aiv
hiv
ebovhiv
lasvhiv
produc
transient
cotransfect
human
cell
use
polyethyleniminebas
transfect
protocol
plasmid
encod
haneuraminidas
na
replicationdefect
hiv
vector
use
transient
cotransfect
cell
five
hour
transfect
cell
wash
phosphatebuff
salin
ml
fresh
medium
ad
plate
mm
fortyeight
hour
transfect
supernat
collect
filter
pore
size
filter
nalgen
rochest
ny
pseudovirion
stock
store
prior
use
target
cell
seed
white
flatbottom
plate
culturpl
perkinelm
waltham
densiti
cellswel
ml
assay
medium
use
janu
liquid
handler
mdt
modular
dispens
technolog
perkinelm
incub
co
high
humid
twentyfour
hour
later
ml
pseudovirion
per
well
extract
ad
plate
pin
tool
v
p
scientif
san
diego
ca
result
final
concentr
mgml
extract
plate
incub
co
hr
incub
ml
neolit
perkinelm
ad
well
use
janu
liquid
handler
mdt
plate
incub
room
temperatur
min
luciferas
activ
measur
envis
plate
reader
perkinelm
tissu
cultur
plate
seed
cellswel
cell
incub
hr
co
high
humid
dmso
pb
use
neg
control
ic
cell
infect
influenza
pseudoviru
along
serial
dilut
extract
fortyeight
hour
post
infect
luciferas
read
use
ml
neolit
substrat
cc
cell
treat
fresh
media
plu
serial
dilut
extract
fortyeight
hour
later
cell
viabil
measur
use
ml
celltiterglo
substrat
promega
madison
wi
ic
cc
determin
fit
doserespons
curv
pseudoviru
control
well
fourparamet
logist
regress
graphpad
prism
select
index
si
calcul
follow
equat
cc
ic
extract
si
consid
hit
cell
seed
well
plate
cellswel
hr
prior
experi
cell
incub
pseudovirion
hr
allow
viru
attach
cell
viru
remov
cell
wash
cold
pb
two
time
fresh
media
ad
temperatur
shift
trigger
viru
entri
differ
time
point
viru
entri
extract
tcm
azt
mm
introduc
assess
impact
viru
entri
triplic
well
use
time
point
control
infect
cell
cultur
treat
drug
vehicl
dmso
pb
viru
infect
measur
hr
postinfect
describ
luciferas
level
determin
luminesc
signal
well
measur
use
envis
plate
reader
data
export
excel
style
file
median
luminesc
signal
sampl
plate
calcul
signal
well
normal
plate
sampl
median
percentag
inhibit
inhibit
calcul
normal
signal
hit
extract
list
gener
separ
screen
three
virus
appli
variou
inhibit
cutoff
share
hit
virusspecif
hit
pick
compar
list
avian
influenza
viru
ebola
viru
lassa
viru
classifi
highli
pathogen
virus
thu
studi
virus
requir
biosafeti
level
contain
overcom
obstacl
effort
identifi
antivir
entri
inhibitor
virus
adopt
surrog
system
allow
us
perform
initi
screen
facil
wang
et
al
human
immunodefici
base
surrog
assay
wide
use
us
other
investig
entri
mechan
highli
pathogen
envelop
virus
filovirus
manicassami
et
al
manicassami
rong
avian
influenza
viru
guo
et
al
sever
acut
respiratori
syndrom
coronaviru
sarscov
guo
et
al
system
also
use
identifi
develop
entri
inhibitor
antivir
guo
et
al
basu
et
al
studi
describ
materi
method
follow
three
type
pseudovirion
ebov
hiv
ebola
glycoprotein
gp
incorpor
surfac
aiv
hiv
avian
influenza
viru
ha
lasv
hiv
lassa
arenaviru
gp
produc
use
evalu
chines
medicin
herbal
extract
effect
extract
three
type
pseudovirion
could
directli
compar
thu
put
virusspecif
share
hit
extract
could
easili
identifi
one
round
screen
technic
depict
figur
approxim
cell
seed
well
twentyfour
hour
later
set
plate
cell
replac
one
type
hiv
pseudovirion
ebov
aiv
lasv
predetermin
amount
individu
herbal
extract
robot
dispens
plate
hr
incub
luciferas
substrat
directli
ad
well
luciferas
activ
well
measur
figur
show
luciferas
report
gave
high
level
signal
compar
basalbackground
signal
signaltonois
ratio
sb
three
pseudovirus
respect
coeffici
variat
cv
calcul
duplic
well
use
indic
assay
reproduc
median
cv
three
screen
rang
indic
screen
reproduc
excel
sinc
z
factor
commonli
use
statist
paramet
assess
screen
qualiti
zhang
et
al
use
assess
qualiti
overal
screen
z
factor
calcul
normal
signal
dmso
azt
control
well
plate
follow
equat
std
dmso
std
azt
mean
dmso
mean
azt
shown
figur
z
factor
valu
three
parallel
screen
indic
overal
qualiti
screen
excel
signal
dmso
pb
azt
control
well
normal
plate
median
azt
use
posit
control
hiv
revers
transcriptas
inhibitor
inhibit
infect
hivbas
pseudotyp
virus
dmso
pb
use
neg
control
shown
figur
dmso
pb
signific
differ
neg
control
posit
control
azt
lower
signal
compar
dmso
pb
control
figur
repres
gaussian
distribut
normal
signal
screen
normal
signal
obtain
divid
measur
signal
well
median
luciferas
signal
sampl
well
plate
aiv
screen
show
broad
bellshap
normal
signal
distribut
contrast
lasv
screen
show
slightli
posit
skew
distribut
ebov
screen
show
greatli
posit
skew
distribut
great
posit
skew
distribut
suggest
sampl
ebov
screen
greatli
reduc
luciferas
activ
implic
inhibit
sampl
ebov
analysi
three
parallel
screen
allow
us
rapidli
identifi
classifi
put
entri
inhibitor
ebov
aiv
lasv
shown
tabl
use
inhibit
cutoff
hit
herbal
extract
identifi
ebov
aiv
lasv
base
three
individu
screen
respect
howev
threeway
comparison
reveal
herbal
extract
could
classifi
put
ebovspecif
entri
inhibitor
tabl
also
show
herbal
extract
belong
share
hit
inhibit
three
pseudoviru
screen
suggest
herbal
extractseith
block
entri
three
virus
block
hiv
replic
toxic
test
concentr
mgml
class
extract
evalu
futur
determin
step
viral
entri
timeofaddit
experi
perform
experi
select
prunella
vulgari
l
highest
si
test
variou
time
point
along
azidothymidin
azt
pb
control
briefli
cell
incub
ebola
pseudoviru
one
hour
allow
viral
attach
cell
viru
wash
cell
temperatur
shift
trigger
viru
entri
extract
control
ad
well
variou
time
point
hr
shown
figur
azt
work
postfus
revers
transcriptas
hiv
still
inhibitori
effect
later
time
point
hr
extract
prunella
vulgari
l
show
inhibit
earli
time
point
hr
suggest
extract
work
earli
attach
step
filovir
entri
remaind
extract
exhibit
inhibitori
effect
earlier
azt
suggest
extract
work
postattach
step
prior
membran
fusion
step
identifi
put
ebov
hit
use
criteria
maxim
inhibit
ebov
inhibit
aiv
lasv
primari
hit
pick
confirm
elimin
effect
cytotox
use
atp
content
assay
si
activ
herbal
extract
report
ratio
cc
ic
seven
confirm
hit
si
list
tabl
ii
divid
seven
action
indic
base
chines
medicin
herb
drain
fire
regul
qi
clear
heat
elimin
toxin
drain
fire
transform
phlegmcold
reliev
cough
wheez
tabl
ii
evalu
herbal
extract
discuss
report
adopt
previou
ht
assay
protocol
screen
herbal
extract
entri
inhibitor
sever
highli
pathogen
virus
identifi
eight
herbal
extract
block
ebov
entri
although
activ
compon
extract
need
isol
identifi
valid
futur
work
result
repres
proofofprincipl
investig
demonstr
ht
assay
use
rapid
screen
ebov
aiv
lasv
virus
antivir
inhibitor
chines
medicin
herb
natur
product
strategi
particularli
use
highli
pathogen
virus
ebola
viru
avian
influenza
viru
lassa
viru
sinc
hiv
vectorbas
surrog
system
allow
us
perform
high
throughput
screen
biosafeti
level
contain
instead
infecti
virus
allevi
safeti
concern
use
sever
virus
screen
simultan
sequenti
easili
identifi
put
entri
inhibitor
differ
virus
reduc
number
falseposit
hit
see
tabl
tradit
chines
medicin
hold
uniqu
posit
among
tradit
medicin
long
histori
china
mani
extract
tradit
chines
medicin
herb
proven
antivir
activ
jassim
naji
gener
low
toxic
cheap
readili
access
use
pseudovirion
entri
system
test
four
hundr
chines
herb
extract
show
extract
gardenia
jasminoid
elli
citru
aurantium
l
viola
yedoensi
makino
prunella
vulgari
l
coix
lacrymajobi
l
var
mayuen
roman
stapf
pinellia
ternata
thunb
breit
moru
alba
l
exhibit
potent
inhibitori
activ
ebov
glycoprotein
entri
extract
test
tabl
ii
previou
report
show
citru
aurantium
l
display
antihcv
activ
ho
et
al
fig
time
addit
experi
give
insight
extract
mechan
ebola
pseudoviru
incub
cell
hr
hr
incub
viru
remov
temperatur
shift
trigger
intern
prunella
vulgari
l
mgml
azt
mm
extract
vehicl
pb
introduc
differ
time
point
infect
extract
effect
assess
describ
materi
method
data
normal
vehicl
pb
error
bar
repres
standard
deviat
extract
viola
yedoensi
makino
high
inhibitori
activ
toward
ngan
et
al
rsv
et
al
vitro
extract
prunella
vulgari
l
specif
activ
herp
simplex
viru
hsv
xu
et
al
yao
et
al
moru
alba
l
show
activ
herp
simplex
viru
type
du
et
al
hiv
influenza
viru
hbv
geng
et
al
demonstr
extract
pinellia
ternata
thunb
breit
display
potenti
inhibitori
activ
ebovgp
entri
chines
medicin
herb
merit
investig
promis
antivir
due
rich
sourc
low
cost
low
cytotox
wide
accept
strong
antivir
properti
possibl
mechan
action
drug
inhibit
ebov
entri
remain
unknown
detail
chemic
research
identifi
purifi
activ
ingredi
facilit
mechanist
analys
applic
overal
although
experi
need
fulli
understand
possibl
use
herbal
extract
virus
infect
describ
surrog
pseudoviru
entri
assay
use
ht
facil
rapid
screen
extens
herbal
collect
identif
one
extract
prunella
vulgari
l
zhang
et
al
previous
known
inhibit
ebola
viru
entri
repurpos
screen
support
use
approach
also
detect
prunella
vulgari
l
could
block
earli
attach
step
ebola
entri
time
addit
experi
hope
screen
effort
result
identif
novel
herbal
extract
develop
drug
treat
ebola
viru
infect
highli
pathogen
virus
chines
medicin
herb
may
use
drug
discoveri
develop
antiebov
